We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1B
AUM Growth
+$81M
Cap. Flow
+$45.6M
Cap. Flow %
4.55%
Top 10 Hldgs %
62.52%
Holding
4,698
New
814
Increased
789
Reduced
1,481
Closed
1,566

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.3M
2
MSFT icon
Microsoft
MSFT
+$11.7M
3
XOM icon
ExxonMobil
XOM
+$10.9M
4
BAC icon
Bank of America
BAC
+$8.84M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.82M

Sector Composition

Rank Sector Weight
1 Financials 1.65%
2 Technology 1.48%
3 Materials 1.36%
4 Healthcare 1.28%
5 Industrials 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XNCR icon
2676
Xencor
XNCR
$1.49B
$2K ﹤0.01%
+100
New +$2.41K
XOMA
2677
DELISTED
Xoma
XOMA
$2K ﹤0.01%
300
-1,304
-81% -$6.7K
YHGJ icon
2678
Yunhong Green CTI Ltd
YHGJ
$8.15M
$2K ﹤0.01%
40
-7
-15% -$413
PRKS icon
2679
United Parks & Resorts
PRKS
$2.09B
$2K ﹤0.01%
100
-3,287
-97% -$61.1K
QVCGB
2680
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
$2K ﹤0.01%
+2
New +$1.94K
USAP
2681
DELISTED
Universal Stainless & Alloy
USAP
$2K ﹤0.01%
136
-27
-17% -$409
SMCP
2682
DELISTED
AlphaMark Actively Managed Small Cap ETF
SMCP
$2K ﹤0.01%
+100
New +$2.35K
SAVE
2683
DELISTED
Spirit Airlines, Inc.
SAVE
$2K ﹤0.01%
38
-1,625
-98% -$86.9K
ITI
2684
DELISTED
Iteris, Inc.
ITI
$2K ﹤0.01%
350
-4,620
-93% -$22.5K
ASXC
2685
DELISTED
Asensus Surgical, Inc.
ASXC
$2K ﹤0.01%
100
-501
-83% -$8.68K
TPHS
2686
DELISTED
Trinity Place Holdings Inc.com
TPHS
$2K ﹤0.01%
+295
New +$2.38K
EVBG
2687
DELISTED
Everbridge, Inc. Common Stock
EVBG
$2K ﹤0.01%
76
-1,811
-96% -$34.3K
MRNS
2688
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2K ﹤0.01%
+327
New +$1.76K
TWNK
2689
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$2K ﹤0.01%
125
-7,120
-98% -$106K
FRGI
2690
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$2K ﹤0.01%
+100
New +$2.53K
ZYNE
2691
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$2K ﹤0.01%
+100
New +$1.99K
NATI
2692
DELISTED
National Instruments Corp
NATI
$2K ﹤0.01%
60
-613
-91% -$19.5K
PRTK
2693
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2K ﹤0.01%
+106
New +$1.67K
FRBK
2694
DELISTED
Republic First Bancorp Inc
FRBK
$2K ﹤0.01%
300
-331
-52% -$2.62K
SAL
2695
DELISTED
Salisbury Bancorp, Inc.
SAL
$2K ﹤0.01%
+120
New +$2.31K
AJRD
2696
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$2K ﹤0.01%
100
-2,449
-96% -$48.4K
EMCF
2697
DELISTED
Emclaire Financial Corp
EMCF
$2K ﹤0.01%
+64
New +$1.78K
ABMD
2698
DELISTED
Abiomed Inc
ABMD
$2K ﹤0.01%
14
-260
-95% -$30.1K
FNHC
2699
DELISTED
FedNat Holding Company Common Stock
FNHC
$2K ﹤0.01%
100
-7,972
-99% -$152K
MN
2700
DELISTED
MANNING & NAPIER, INC.
MN
$2K ﹤0.01%
403
-731
-64% -$4.81K

Similar funds

Tower Research Capital (TRC)'s Q1 2017 Portfolio in Review

As of Q1 2017, Tower Research Capital (TRC) held 4,698 positions worth $1B, up 8.8% from $921M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Tower Research Capital (TRC) deployed $45.6M of net new capital in Q1 2017, opening 814 new positions and adding to 789 existing holdings. Its largest new stake was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.

By sector, the portfolio is most concentrated in Financials at 1.7% of assets, down from 14% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Apple, an estimated $13.3M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2017 buy was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $213M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2017 reduction was Apple, cutting an estimated $13.3M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2017, selling an estimated $8.82M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 63% of its $1B portfolio in Q1 2017.
  • Tower Research Capital (TRC) opened 814 new positions and closed 1,566 in Q1 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 8.8% quarter-over-quarter to $1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.